1 Mid Cap, 1 Large Cap Pharma Stocks Set To Trade 400% & 600% Ex-Dividend On July 28

Zydus Lifesciences Ltd. and Alembic Pharmaceuticals Ltd. are two large-cap & Midcap stock Pharmaceuticals stocks that are set to trade ex-dividend next week on July 28, 2023. Both the stock traded ex-dividend for 400% & 600% final dividend next week. On Thursday, the large-cap stock hit a new 52-week high, while the midcap stock rallied 7.68% on BSE. Check below to know more:

1. Zydus Lifesciences Ltd.

Large-cap Pharma stock, Zydus Lifesciences is set to trade 600% ex-dividend next week on July 28, 2023. It has a market cap of Rs 62,458.06 Crore.

On May 18, 2023, the Board of Directors of Zydus Lifescience declared a final dividend of Rs 6 /share of Re 1 each i.e. 600% with a record date as Friday, July 28, 2023, for the financial year 2022-23. The payment of the dividend will be done by August 16, 2023.

According to the regulatory filing by the Board of Directors of Zydus Lifesciences Ltd., "final dividend of Rs. 6.00/- (@ 600%) per equity share of Re. 1/- each, subject to approval of the shareholders at the AGM and the Record Date as Friday, July 28, 2023, in compliance with regulation 42(1) of the Listing Regulations, to determine the list of shareholders entitled to receive the final dividend for the Financial Year ended on March 31, 2023, payment of which shall be subject to the approval by the members at the AGM. The Company shall make the payment of dividend, subject to deduction of tax at source, on or after August 16, 2023 subject to the approval of the same by the shareholders at the AGM."

Stock Outlook

Last traded shared price of Zydus Lifescience is Rs 617.05 per share, up 1.56% compared to its previous close.

The stock touched a new 52-week high today with Rs 618.80 intraday high and Rs 605.45 intraday low on BSE. Its 52-week high is Rs 618.80 per share and 52-week low is Rs 338 per share, respectively.

It jumped 4.35% in 1 week, 11.01% in 1 month, 20.15% in 3 months and 41.01% in 6 months, respectively. It gained 72.02% in 1 year, 64.99% in 3 years and 78.34% in 5 years, respectively.

2. Alembic Pharmaceuticals

Midcap Pharma stock, Alembic Pharmaceuticals to go ex-dividend on July 28, 2023, for 400% final dividend. The stock has a market cap of Rs 14,021.83 Crore.

On May 05, 2023, the board fixed 'Record Date' as July 28, 2023, for Final Dividend. The Board declared 400% final dividend i.e. Rs 8/- per Equity Share having face value of Rs 2/- each.

Alembic Pharmaceuticals Ltd. in an exchange filing has said, "this is to inform the exchange that the Company has fixed Friday, 28th July, 2023 as the Record Date for determining the entitlement of members of the Company to receive dividend for the financial year ended 31st March, 2023. The payment of dividend will be made on or from Friday, 8th August, 2023, upon the same being approved at the Annual General Meeting scheduled to be held on 4th August, 2023."

In an exchange filing on May 05, 2023, the company said, "Recommended a dividend of Rs. 8/- (400%) per Equity Share having face value of Rs. 2/- each, subject to approval of the Shareholders at the ensuing Annual General Meeting."

Stock Outlook

Alembic Pharmaceuticals stock last traded at Rs 713.35 per share, up 7.68% from its previous close with intraday high and low of Rs 720.55 and Rs 662.45, respectively.

The stock surged 9.52% in 1 week, and 17.41% in 1 month, respectively. It gained 34.01% in 3 months, and 28.75% in 6 months, respectively. In 1 and 3 years, years it declined 0.01% and 29.65%, respectively. It gained 34.35% in 3 years.

Disclaimer

The stocks just highlight the dividends and are not a recommendation to buy, sell or hold. We have not done fundamental or technical analysis and have no opinion on the stock mentioned. Neither the author nor Greynium Information Technologies should be held liable for any losses. Please consult a professional advisor.